VIVO Cannabis

MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million

Retrieved on: 
Tuesday, September 5, 2023
VIVO Cannabis, TSX, Cannabis, Acquisition, FSE, Side road, VIVO, Sale, Drug

MediPharm Labs sold vacant land in Napanee, Ontario last utilized in 2021 for outdoor cannabis growing activities.

Key Points: 
  • MediPharm Labs sold vacant land in Napanee, Ontario last utilized in 2021 for outdoor cannabis growing activities.
  • The net cash proceeds of $1.9 million adds non-dilutive capital to MediPharm's strong balance sheet.
  • TORONTO, Sept. 5, 2023 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed the sale of vacant land for net proceeds of $1.9 million dollars.
  • On August 30, 2023, MediPharm completed the sale of 291 Kimmett's Side Road, Napanee, Ontario, for net proceeds of $1.9 million.

Klavi, an SaaS platform that provides Open Finance solutions, receives a USD 15 million investment

Retrieved on: 
Friday, August 12, 2022
API, CVC, Industry, CEO, CIP, Technology, Growth, Investment, Leadership, Classification, Software as a service, Vivo, SA, BV, Solution, USD, VIVO Cannabis, Cryptocurrency, Financial services

SÃO PAULO, Aug. 12, 2022 /PRNewswire/ -- Klavi — a leading SaaS platform in data aggregation, analytics, and API services, who aims to empower companies with its Open Finance solutions , has just received an investment of USD 15 million. The Series A investment round included investors like GSR Ventures and two Brazilian companies, Iporanga Ventures and Parallax Ventures. Klavi also received investments from CIP SA and Vivo Ventures (Vivo's CVC). For both companies, this is the first operation of its kind. The financing includes an additional closing of up to 90 days, which will bring in more investors.

Key Points: 
  • The Series A investment round included investors like GSR Ventures and two Brazilian companies, Iporanga Ventures and Parallax Ventures.
  • "This is an important momentand theinvestment will foster and create solutions so that our clients can generate value from Open Finance", explained Bruno Chan, CEO of Klavi.
  • "With the maturation of Open Finance, we're seeing a huge gap between the data received by companies, and their use thereof.
  • In 2021, it received a seed investment of USD 1.25million, led by Iporanga Ventures, along with participation from Parallax Ventures.

BioHarvest Sciences Inc. Announces a CAD 4 Million Private Placement to Accelerate Its Cannabis Development Program and Production Capacity in Israel

Retrieved on: 
Wednesday, August 4, 2021
Entheogens, Euphoriants, Medicinal plants, Psychoactive drugs, Plants, Cannabis, Cannabis smoking, Rosids, VIVO Cannabis

The funds will enhance the Company's cash position to:

Key Points: 
  • The funds will enhance the Company's cash position to:
    Accelerate the Company's Cannabis development program.
  • Provide for the required system upgrades for the conversion of the existing 2 Tons/year VINIA facility into a Cannabis production facility to be operational in H1/2022.
  • Based in Vancouver BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology.
  • Further, by adapting this technology to the Cannabis plant, and building adequate production capacity, BioHarvest Sciences Inc.'s objective is to become a leading supplier of Cannabis for both medicinal and legal recreational purposes.

BevCanna Signs Agreement to Infuse Vertosa’s Emulsions into Its Cannabis Beverages

Retrieved on: 
Wednesday, May 19, 2021
Pharmaceutical, Alternative medicine, General Health, Health, Specialty, Food, Beverage, Online Retail, Retail, Physical sciences, Natural sciences, Cannabis, Cannabis smoking, Cannabis culture, Cannabis cultivation, Cannabis in Ontario, VIVO Cannabis, Emulsion, BevCanna Enterprises Inc., Vertosa, BEVCANNA ENTERPRISES INC., VERTOSA

b'Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (\xe2\x80\x9cBevCanna\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d) announced today that it signed a cannabis supply agreement with ABcann Medicinals Inc. ("ABcann), a wholly-owned subsidiary of VIVO Cannabis Inc. (TSX:VIVO) , to infuse Vertosa cannabis emulsions into select BevCanna in-house and white-label products, including the Keef Brands line that BevCanna will launch in Canada this summer.\nBevCanna will infuse Vertosa emulsions, the #1 cannabis emulsion in the U.S., into its Canadian cannabis beverages.

Key Points: 
  • b'Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (\xe2\x80\x9cBevCanna\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d) announced today that it signed a cannabis supply agreement with ABcann Medicinals Inc. ("ABcann), a wholly-owned subsidiary of VIVO Cannabis Inc. (TSX:VIVO) , to infuse Vertosa cannabis emulsions into select BevCanna in-house and white-label products, including the Keef Brands line that BevCanna will launch in Canada this summer.\nBevCanna will infuse Vertosa emulsions, the #1 cannabis emulsion in the U.S., into its Canadian cannabis beverages.
  • Vertosa\xe2\x80\x99s emulsions are proven to accelerate onset time to an average of eight minutes, prolong shelf-life, increase bioavailability and improve the taste profile of the Company\xe2\x80\x99s cannabis-infused products.
  • Vertosa\xe2\x80\x99s pre-suspended, water-compatible solutions are incredibly homogenous and stable products that are customized and generated onsite at ABcann.
  • The agreement with ABcann provides BevCanna with access to the emulsions for its portfolio of products.\n\xe2\x80\x9cThis emulsion technology will be game-changing in its ability to accelerate onset time and enhance the sensory experience of our cannabis-infused beverages, among other benefits,\xe2\x80\x9d said Melise Panetta, President of BevCanna.

Medical Marijuana Market to grow by $ 27.72 bn during 2021-2025, Aphria Inc. and Aurora Cannabis Inc. emerge as Key Contributors to growth| Technavio

Retrieved on: 
Monday, April 26, 2021
Cannabis, Companies, Canopy Growth, S&P/TSX 60, Tilray, Aurora Cannabis, Aphria, VIVO Cannabis, Cannabis in Canada

b"NEW YORK, April 26, 2021 /PRNewswire/ -- Technavio has monitored themedical marijuana marketin its latest market research report.

Key Points: 
  • b"NEW YORK, April 26, 2021 /PRNewswire/ -- Technavio has monitored themedical marijuana marketin its latest market research report.
  • Aphria Inc., Aurora Cannabis Inc., Cannabis Sativa Inc., Canopy Growth Corp., Cronos Group Inc., DEMECAN Holding GmbH, GW PharmaceuticalsPlc, Medical Marijuana Inc., Tilray Inc., and VIVO Cannabis Inc. are some of the major market participants.
  • The plans to increase the production and availability of medical marijuana by governments will offer immense growth opportunities.
  • In a bid to help players strengthen their market foothold, this medical marijuana marketforecast report provides a detailed analysis of the leading market vendors.

Aleafia Health Enters Supply Agreement with Cannabis Brand House BLLRDR

Retrieved on: 
Tuesday, December 15, 2020
Entheogens, Euphoriants, Medicinal plants, Cannabis, Psychoactive drugs, Cannabis smoking, Rosids, Canopy Growth, VIVO Cannabis

TORONTO, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Aleafia Health Inc.s (TSX: AH, OTC: ALEAF) (Aleafia Health or the Company) wholly-owned subsidiary Emblem Cannabis Corporation has entered into a definitive supply agreement with cannabis brand house Robes Cannabis Inc. (dba BLLRDR).

Key Points: 
  • TORONTO, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Aleafia Health Inc.s (TSX: AH, OTC: ALEAF) (Aleafia Health or the Company) wholly-owned subsidiary Emblem Cannabis Corporation has entered into a definitive supply agreement with cannabis brand house Robes Cannabis Inc. (dba BLLRDR).
  • The agreement gives the Company the exclusive rights to sell BLLRDRs portfolio of rare, highly sought-after cannabis cultivars and other products in the Canadian medical cannabis market.
  • Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets.
  • Aleafia Health owns three significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history.

Supreme Cannabis Announces Voting Results of the 2020 Annual General Meeting of Shareholders

Retrieved on: 
Tuesday, November 10, 2020
Herbalism, Medicinal plants, Health sciences, Branches of biology, Cannabis, Cannabis smoking, Entheogens, Medical cannabis, Canopy Growth, VIVO Cannabis

The Supreme Cannabis Company, Inc. , (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), is a global diversified portfolio of distinct cannabis companies, products and brands.

Key Points: 
  • The Supreme Cannabis Company, Inc. , (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), is a global diversified portfolio of distinct cannabis companies, products and brands.
  • Since 2014, the Company has emerged as one of the world's most premium producers of recreational, wholesale and medical cannabis products.
  • Supreme Cannabis' portfolio of brands caters to diverse consumer and patient experiences, with brands and products that address recreational, wellness, medical and new consumer preferences.
  • Supreme Cannabis addresses national and international medical cannabis opportunities through its premium Truverra brand.

Supreme Cannabis Files Prospectus Supplement

Retrieved on: 
Wednesday, September 2, 2020
Cannabis, Cannabis smoking, Entheogens, Euphoriants, Medicine, Canopy Growth, VIVO Cannabis

The Supreme Cannabis Company, Inc. , (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), is a global diversified portfolio of distinct cannabis companies, products and brands.

Key Points: 
  • The Supreme Cannabis Company, Inc. , (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), is a global diversified portfolio of distinct cannabis companies, products and brands.
  • Supreme Cannabis' portfolio of brands caters to diverse consumer and patient experiences, with brands and products that address recreational, wellness, medical and new consumer preferences.
  • Supreme Cannabis addresses national and international medical cannabis opportunities through its premium Truverra brand.
  • View original content to download multimedia: http://www.prnewswire.com/news-releases/supreme-cannabis-files-prospectu...
    SOURCE The Supreme Cannabis Company, Inc.

MediPharm Labs Australia Enters Into New Supply Agreement With VIVO Cannabis and Prepares to Commence Sales

Retrieved on: 
Friday, June 19, 2020
Medicine, Cannabis, Drugs, Herbalism, Medicinal plants, Appetite stimulants, Entheogens, Euphoriants, VIVO Cannabis, Medical cannabis, Tetrahydrocannabinol, Legality of cannabis

TORONTO, June 19, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (MediPharm Labs or the Company) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced that its subsidiary, MediPharm Labs Australia Pty.

Key Points: 
  • TORONTO, June 19, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (MediPharm Labs or the Company) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced that its subsidiary, MediPharm Labs Australia Pty.
  • Ltd. (MediPharm Labs Australia) has entered into an agreement to supply pharmaceutical-quality (GMP certified), formulated cannabis oil products to Beacon Medical Australia Pty.
  • Ltd. (Beacon Medical Australia), a subsidiary of VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) (VIVO Cannabis).
  • Under the agreement with Beacon Medical Australia, which has an initial one-year term subject to renewal, MediPharm Labs Australia will supply a full range of GMP-certified, formulated CBD and THC cannabis oil products to Beacon Medical Australia for further distribution under its own branding.

Why Those in the U.S. Cannabis Markets are Looking Forward to 2020

Retrieved on: 
Wednesday, January 22, 2020
Cannabis, Companies, OTC Markets Group, Aphria, VIVO Cannabis, MedMen, Legality of cannabis

California has already begun to take efforts to drive down, if not eliminate the illicit growth & sales of cannabis.

Key Points: 
  • California has already begun to take efforts to drive down, if not eliminate the illicit growth & sales of cannabis.
  • Though there was a lot of bad news, there is still plenty to look forward to in 2020.
  • The first bit of good news is that it's normal for markets to correct frequently as well as early on.
  • Active cannabis companies in the markets this week include: Sugarmade, Inc. (OTCQB: SGMD), Smart Cannabis Corp. (OTCPK: SCNA), Aphria Inc. (NYSE: APHA) (TSX: APHA), VIVO Cannabis Inc. (TSX-V: VIVO) (OTCQX: VVCIF), MedMen Enterprises Inc. (CSE: MMEN) (OTCQB: MMNFF).